ZA986324B - Composition for the treatment of immunodeficiency disease - Google Patents
Composition for the treatment of immunodeficiency diseaseInfo
- Publication number
- ZA986324B ZA986324B ZA986324A ZA986324A ZA986324B ZA 986324 B ZA986324 B ZA 986324B ZA 986324 A ZA986324 A ZA 986324A ZA 986324 A ZA986324 A ZA 986324A ZA 986324 B ZA986324 B ZA 986324B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- composition
- immunodeficiency disease
- immunodeficiency
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20837997 | 1997-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA986324B true ZA986324B (en) | 1999-02-02 |
Family
ID=16555308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA986324A ZA986324B (en) | 1997-07-18 | 1998-07-16 | Composition for the treatment of immunodeficiency disease |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1038533A4 (ja) |
CN (1) | CN1264308A (ja) |
AU (1) | AU8242398A (ja) |
CA (1) | CA2296503A1 (ja) |
HU (1) | HUP0003236A3 (ja) |
TW (1) | TW536400B (ja) |
WO (1) | WO1999003504A1 (ja) |
ZA (1) | ZA986324B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19923961A1 (de) | 1999-05-25 | 2000-11-30 | Euro Nippon Kayaku Gmbh | Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen |
DE10361944A1 (de) * | 2003-12-31 | 2005-07-28 | Viromics Gmbh | Mittel zur Hemmung der Virusreplikation durch Regulation der Proteinfaltung |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0794424B2 (ja) * | 1987-09-30 | 1995-10-11 | 財団法人微生物化学研究会 | 新スパガリン関連化合物およびその製造法 |
-
1998
- 1998-07-14 TW TW087111450A patent/TW536400B/zh not_active IP Right Cessation
- 1998-07-15 WO PCT/JP1998/003175 patent/WO1999003504A1/ja not_active Application Discontinuation
- 1998-07-15 CA CA002296503A patent/CA2296503A1/en not_active Abandoned
- 1998-07-15 EP EP98932529A patent/EP1038533A4/en not_active Withdrawn
- 1998-07-15 CN CN98807357A patent/CN1264308A/zh active Pending
- 1998-07-15 AU AU82423/98A patent/AU8242398A/en not_active Abandoned
- 1998-07-15 HU HU0003236A patent/HUP0003236A3/hu unknown
- 1998-07-16 ZA ZA986324A patent/ZA986324B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1038533A4 (en) | 2003-01-02 |
TW536400B (en) | 2003-06-11 |
CN1264308A (zh) | 2000-08-23 |
AU8242398A (en) | 1999-02-10 |
HUP0003236A2 (hu) | 2001-02-28 |
HUP0003236A3 (en) | 2003-05-28 |
EP1038533A1 (en) | 2000-09-27 |
WO1999003504A1 (fr) | 1999-01-28 |
CA2296503A1 (en) | 1999-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1017379A4 (en) | THERAPEUTIC COMPOSITIONS | |
EP1043991A4 (en) | TREATMENT OF ALZHEIMER DISEASE | |
AP9801414A0 (en) | Combination effective for the treatment of impotence | |
GB9700899D0 (en) | Novel treatment | |
ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
IL121730A0 (en) | Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease | |
ZA977874B (en) | Pharmaceutical compositions for treating viral diseases | |
ZA982255B (en) | Process for the preparation of arylmalonates. | |
IL120005A (en) | Pharmaceutical compositions for the treatment of the eye | |
ZA987741B (en) | Process for the preparation of oxazaphosphorine-2-amines | |
ZA986324B (en) | Composition for the treatment of immunodeficiency disease | |
EP0755262A4 (en) | PNEUMOPATHY TREATMENT COMPOSITION | |
HUP0001757A3 (en) | Improved process for the preparation of halo-4-phenoxyquinolines | |
IL135553A0 (en) | Process for the preparation of azacycloalkyalkanoyl pseudotetrapeptides | |
ZA982395B (en) | Therapeutic composition | |
HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
GB9807032D0 (en) | Process for the preparation of (S)-3-carbethoxy-3-benzylpiperidine | |
GB2354946B (en) | Means for the treatment of prion disease | |
KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
IL132237A0 (en) | Process for the preparation of 3-isochromanome | |
ZA981924B (en) | Process for the preparation of n-carboxylalkyl-3-fluoro-4- dialkylaminoanilines | |
IL121227A0 (en) | Composition for the treatment of seborrhea | |
GB9721692D0 (en) | Novel treatment | |
ZA9811598B (en) | A substance or composition for the treatment of cancer. |